Long-term cardiac rehabilitation and exercise training programs improve metabolic parameters in metabolic syndrome patients with and without coronary heart disease

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 18, Issue 2, 2008, Pages 142-151

  Gayda, Mathieu ^a   Brun, Carlos ^a   Juneau, Martin ^a   Levesque, Sylvie ^a   Nigam, Anil ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Cardiac rehabilitation; Coronary heart disease; Exercise training; Metabolic syndrome

Indexed keywords

LIPID;

AGED; ARTICLE; BLOOD; BODY MASS; BODY WEIGHT; CORONARY ARTERY DISEASE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEALTH CARE QUALITY; HUMAN; KINESIOTHERAPY; LIFESTYLE; LONG TERM CARE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; TIME; TREATMENT OUTCOME;

AGED; BODY MASS INDEX; BODY WEIGHT; CORONARY DISEASE; EXERCISE TEST; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; HUMANS; LIFE STYLE; LIPIDS; LONG-TERM CARE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 39549087196     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2006.07.003     Document Type: Article

References (44)

1. McGill Jr. H.C., McMahan C.A., Herderick E.E., Zieske A.W., Malcom G.T., Tracy R.E., et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 105 (2002) 2712-2718
2. The DECODE Study Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and non-cardiovascular diseases?. Diabetes Care 26 (2003) 688-696
3. Eberly L.E., Stamler J., Neaton J.D., and Multiple Risk Factor Intervention Trial Research Group. Relation of triglyceride levels, fasting and non-fasting, to fatal and non-fatal coronary heart disease. Arch Intern Med 163 (2003) 1077-1083
4. Grundy S.M., Balady G.J., Criqui M.H., Fletcher G., Greenland P., Hiratzka L.F., et al. Primary prevention of coronary heart disease: guidance from Framingham. A statement for healthcare professionals from the AHA task force on risk reduction. Circulation 97 (1998) 1876-1887
5. Rosengren A., Hawken S., Ounpuu S., Sliwa K., Zubaid M., Almahmeed W.A., et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 953-962
6. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
7. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
8. Trevisan M., Liu J., Bahsas F.B., and Menotti A. Syndrome X and mortality: a population-based study. Risk factor and life expectancy research group. Am J Epidemiol 148 (1998) 958-966
9. Nigam A., Bourassa M., Fortier A., Guertin M.C., and Tardif J.C. The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease. Am Heart J 151 (2006) 514-521
10. Ford E.S., Giles W.H., and Mokdad A.H. Increasing prevalence of the metabolic syndrome among U.S. Adults. Diabetes Care 27 (2004) 2444-2449
11. Katzmarzyk P.T., Leon A.S., Wilmore J.H., Skinner J.S., Rao D.C., Rankinen T., et al. Targeting the metabolic syndrome with exercise: evidence from the HERITAGE Family Study. Med Sci Sports Exerc 35 (2003) 1703-1709
12. Katzmarzyk P.T., Church T.S., and Blair S.N. Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men. Arch Intern Med 164 (2004) 1092-1097
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
14. Bouchard C., Leon A.S., Rao D.C., Skinner J.S., Wilmore J.H., and Gagnon J. The HERITAGE family study. Aims, design, and measurement protocol. Med Sci Sports Exerc 27 (1995) 721-729
15. Watkins L.L., Sherwood A., Feinglos M., Hinderliter A., Babyak M., Gullette E., et al. Effects of exercise and weight loss on cardiac risk factors associated with syndrome X. Arch Intern Med 163 (2003) 1889-1895
16. Pearson T.A., Blair S.N., Daniels S.R., Eckel R.H., Fair J.M., Fortmann S.P., et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 106 (2002) 388-389
17. Carroll S., and Dudfield M. What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome. Sports Med 34 (2004) 371-418
18. Couillard C., Despres J.P., Lamarche B., Bergeron J., Gagnon J., Leon A.S., et al. Effects of endurance exercise-training on plasma HDL-cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise-Training and Genetics (HERITAGE) Family Study. Arterioscler Thromb Vasc Biol 21 (2001) 1226-1232
19. Christ M., Iannello C., Iannello P.G., and Grimm W. Effects of a weight reduction program with and without aerobic exercise in the metabolic syndrome. Int J Cardiol 97 (2004) 115-122
20. Milani R.V., and Lavie C.J. Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation. Am J Cardiol 92 (2003) 50-54
21. Gayda M., Juneau M., Lévesque S., Guertin M.C., and Nigam A. Effects of long-term and ongoing cardiac rehabilitation in elderly patients with coronary heart disease. Am J Geriatr Cardiol 15 6 (2006) 345-351
22. Genest J., Frohlich J., Fodor G., McPherson R., and the Working Group on Hypercholesterolemia and Other Dyslipidemias. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. CMAJ 169 (2003) 921-924
23. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
24. Fletcher G.F., Balady G.J., Amsterdam E.A., Chaitman B., Eckel R., Fleg J., et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 104 (2001) 1694-1740
25. Pate R., Blair S., and Durstine J. Metabolic calculations. In: American College of Sports Medicine (Ed). ACSM's guidelines for exercise testing and prescription (1991), Lea & Febiger, Philadelphia p. 296
26. Banz W.J., Maher M.A., Thompson W.G., Bassett D.R., Moore W., Ashraf M., et al. Effects of resistance vs aerobic training on coronary artery disease risk factors. Exp Biol Med (Maywood) 228 (2003) 434-440
27. Hawley J.A. Exercise as a therapeutic intervention for the prevention and treatment of insulin resistance. Diabetes Metab Res Rev 20 (2004) 383-393
28. Milani R.V., and Lavie C.J. Prevalence and effects of non-pharmacologic treatment of "isolated" low-HDL cholesterol in patients with coronary artery disease. J Cardiopulm Rehabil 15 6 (1995) 439-444
29. Milani R.V., and Lavie C.J. Marked reduction in outpatient, impatient and total medical costs with comprehensive work-site primary prevention programs. J Am Coll Cardiol 29 (1997) 49A-50A
30. Katzmarzyk P.T., Church T.S., Janssen I., Ross R., and Blair S.N. Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. Diabetes Care 28 (2005) 391-397
31. Blair S.N., and Church T.S. The fitness, obesity, and health equation: is physical activity the common denominator?. JAMA 292 (2004) 1232-1234
32. Hu F.B., Willett W.C., Li T., Stampfer M.J., Colditz G.A., and Manson J.E. Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med 351 (2004) 2694-2703
33. Blair S.N., and Brodney S. Effects of physical inactivity and obesity on morbidity and mortality: current evidence and research issues. Med Sci Sports Exerc 31 (1999) S646-S662
34. Kodis J., Smith K.M., Arthur H.M., Daniels C., Suskin N., and McKelvie R.S. Changes in exercise capacity and lipids after clinic versus home-based aerobic training in coronary artery bypass graft surgery patients. J Cardiopulm Rehabil 21 1 (2001) 31-36
35. Brochu M., Poehlman E.T., Savage P., Fragnoli-Munn K., Ross S., and Ades P.A. Modest effects of exercise training alone on coronary risk factors and body composition in coronary patients. J Cardiopulm Rehabil 20 3 (2000) 180-188
36. Hamdy O., Ledbury S., Mullooly C., Jarema C., Porter S., Ovalle K., et al. Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 26 (2003) 2119-2125
37. Petersen A.M., and Pedersen B.K. The anti-inflammatory effect of exercise. J Appl Physiol 98 (2005) 1154-1162
38. Billman G.E. Aerobic exercise conditioning: a non-pharmacological anti arrhythmic intervention. J Appl Physiol 92 (2002) 446-454
39. El-Sayed M.S., El-Sayed Ali Z., and Ahmadizad S. Exercise and training effects on blood haemostasis in health and disease: an update. Sports Med 34 (2004) 181-200
40. Fornoni A., and Raij L. Metabolic syndrome and endothelial dysfunction. Curr Hypertens Rep 7 (2005) 88-95
41. Malik S., Wong N.D., Franklin S., Pio J., Fairchild C., and Chen R. Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein. Diabetes Care 28 (2005) 690-693
42. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 107 (2003) 391-397
43. Huggett R.J., Burns J., Mackintosh A.F., and Mary D.A. Sympathetic neural activation in non-diabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 44 (2004) 847-852
44. Nieuwdorp M., Stroes E.S., Meijers J.C., and Buller H. Hypercoagulability in the metabolic syndrome. Curr Opin Pharmacol 5 (2005) 55-59